UMOD p.Cys106Phe

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 14P and 4B. PS3PM1PM5PP2PP3_StrongPP5BS2

The NM_003361.4(UMOD):​c.317G>T​(p.Cys106Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000445 in 1,574,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV001810844: Published functional studies suggest abnormal protein folding and aggregation (PMID:32926855)" and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C106Y) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000042 ( 0 hom. )

Consequence

UMOD
NM_003361.4 missense

Scores

14
4
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:8U:1O:1

Conservation

PhyloP100: 4.13

Publications

11 publications found
Variant links:
Genes affected
UMOD (HGNC:12559): (uromodulin) The protein encoded by this gene is the most abundant protein in mammalian urine under physiological conditions. Its excretion in urine follows proteolytic cleavage of the ectodomain of its glycosyl phosphatidylinosital-anchored counterpart that is situated on the luminal cell surface of the loop of Henle. This protein may act as a constitutive inhibitor of calcium crystallization in renal fluids. Excretion of this protein in urine may provide defense against urinary tract infections caused by uropathogenic bacteria. Defects in this gene are associated with the renal disorders medullary cystic kidney disease-2 (MCKD2), glomerulocystic kidney disease with hyperuricemia and isosthenuria (GCKDHI), and familial juvenile hyperuricemic nephropathy (FJHN). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2013]
UMOD Gene-Disease associations (from GenCC):
  • autosomal dominant medullary cystic kidney disease with or without hyperuricemia
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • glomerulocystic kidney disease with hyperuricemia and isosthenuria
    Inheritance: AD Classification: DEFINITIVE Submitted by: Laboratory for Molecular Medicine
  • familial juvenile hyperuricemic nephropathy type 1
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal dominant medullary cystic kidney disease with hyperuricemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003361.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV001810844: Published functional studies suggest abnormal protein folding and aggregation (PMID: 32926855); SCV002242196: Experimental studies have shown that this missense change affects UMOD function (PMID: 32926855).; SCV001478436: A functional study using a mouse homolog of the UMOD p.Cys106Phe variant suggests that misfolded and aggregated uromodulin engages the kidney's immune system, resulting in auto-antibody and immune complex formation.; SCV004105465: Functional studies using a mouse model showed that this variant results in autoantibodies against aggregated misfolded protein with immune complex formation and kidney fibrosis (Plotkin et al. 2020. PubMed ID: 32926855).
PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 5 uncertain in NM_003361.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr16-20348984-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 807521.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 69 curated pathogenic missense variants (we use a threshold of 10). The gene has 14 curated benign missense variants. Gene score misZ: 0.99836 (below the threshold of 3.09). Trascript score misZ: 0.48416 (below the threshold of 3.09). GenCC associations: The gene is linked to autosomal dominant medullary cystic kidney disease with hyperuricemia, autosomal dominant medullary cystic kidney disease with or without hyperuricemia, familial juvenile hyperuricemic nephropathy type 1, glomerulocystic kidney disease with hyperuricemia and isosthenuria.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.99
PP5
Variant 16-20348984-C-A is Pathogenic according to our data. Variant chr16-20348984-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 94129.
BS2
High AC in GnomAdExome4 at 6 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003361.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UMOD
NM_003361.4
MANE Select
c.317G>Tp.Cys106Phe
missense
Exon 3 of 11NP_003352.2P07911-1
UMOD
NM_001378234.1
c.317G>Tp.Cys106Phe
missense
Exon 3 of 12NP_001365163.1
UMOD
NM_001378235.1
c.317G>Tp.Cys106Phe
missense
Exon 3 of 12NP_001365164.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UMOD
ENST00000396138.9
TSL:5 MANE Select
c.317G>Tp.Cys106Phe
missense
Exon 3 of 11ENSP00000379442.5P07911-1
UMOD
ENST00000396134.6
TSL:2
c.416G>Tp.Cys139Phe
missense
Exon 4 of 12ENSP00000379438.2P07911-5
UMOD
ENST00000863077.1
c.479G>Tp.Cys160Phe
missense
Exon 4 of 12ENSP00000533136.1

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152280
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000109
AC:
2
AN:
184308
AF XY:
0.0000101
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000260
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000422
AC:
6
AN:
1421900
Hom.:
0
Cov.:
39
AF XY:
0.00000426
AC XY:
3
AN XY:
703700
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32558
American (AMR)
AF:
0.00
AC:
0
AN:
38744
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25424
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37350
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81398
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49834
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5720
European-Non Finnish (NFE)
AF:
0.00000366
AC:
4
AN:
1091942
Other (OTH)
AF:
0.0000339
AC:
2
AN:
58930
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152280
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41486
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68050
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000868
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
1
-
not provided (5)
3
-
-
Familial juvenile hyperuricemic nephropathy type 1 (4)
1
-
-
UMOD-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Pathogenic
0.54
D
BayesDel_noAF
Pathogenic
0.53
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.48
T
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.74
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
0.98
D
MutationAssessor
Pathogenic
4.1
H
PhyloP100
4.1
PrimateAI
Benign
0.45
T
PROVEAN
Pathogenic
-4.6
D
REVEL
Pathogenic
0.91
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Varity_R
0.99
gMVP
1.0
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs398123697;
hg19: chr16-20360306;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.